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Abstract
Introduction: Creutzfeldt-Jacob Disease is the most frequently seen type of prion diseases. Its
clinical findings consist of predominantly progressive dementia with a rapid onset, myoclonus, and
also cerebellar, pyramidal, extrapyramidal and visual signs. Definitive diagnosis is established with
histological examination of brain biopsy or autopsy materials. Occurrence of periodical spikes in
EEG, observation of cortical signal alterations during diffusion weighted (DW) MRI studies, and
detection of protein 14-3-3 in cerebrospinal fluid (CSF) substantiate the diagnosis.
Case presentation: Seventy year-old male patient referred with complaints of weakness and
involuntary movements in left arm, changes in behavior, and forgetfulness. He also developed
akinetic mutism after nearly three months. In EEG periodic triphasic waves were seen. Despite the
absence of any apparent pathological finding in T2 and FLAIR MRI, excluding signs of atrophy, on
DW MRI hyperintense signal changes in cortical regions (cortical ribboning) were observed.
Protein 14-3-3 in CSF was detected.
Conclusion: Patients who have progressive dementia and associated atypical features should be
investigated especially with DW MRI. Cortical ribboning is a very useful diagnostic sign for CJD.
Introduction
Creutzfeldt-Jacob Disease (CJD) is a rarely seen neurode-
generative disease among the infectious spongioform
encephalopathies. It has four subtypes as sporadic, famil-
ial, iatrogenic and variant forms thought to be transmitted
with ingestion of infected meat products [1]. Mean age at
the onset is 60 years with a yearly incidence of approxi-
mately 1/1.000.000. Firstly in 1982, Prusiner hypotheti-
cally proposed prions as causative infectious agents of
CJD. In fact, normally a prion (PrPC) is a glycoprotein
found in normal cells of humans and animals. In humans
prion protein gene is localized on the short arm of the
chromosome 20. Methionine/valine polymorphism on
codon 129 of this gene is found to be associated with CJD.
Infective prion (PrPSc) is a posttranslational product
resulting from defective folding of the normal prion.
These abnormal prions accumulate in cells leading to the
formation of vacuolar degeneration and some fibrillar
structures; subsequently brain takes the form of a sponge
resulting in death [2].
In this article a case with a probable sporadic CJD, in
which diagnosis was established based on medical his-
tory, clinical presentation, findings of diffusion weighted
(DW) MRI, EEG and CSF in accordance with clinical diag-
nostic criteria of World Health Organization (WHO) is
presented.
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Case presentation
Three months before referral to our clinics, this 70 year-
old patient experienced complaints such as difficulty in
raising 3rd and 4th digits of his hands, insomnia, irritabil-
ity, inability to find his way home. In cranial MRI bilateral
cerebral cortical atrophy more prominent on the fron-
toparietal region was detected. The condition was evalu-
ated as Alzheimer type dementia and cholinesterase
inhibitors were initiated. To exclude the diagnosis of cer-
vical radiculopathy and motor neuron disease, he under-
went cervical MRI and EMG without detection of any
specific finding. Two months after the onset of his com-
plaints, visual hallucinations and tremor of the right hand
were added. Cranial MRI was repeated without any detec-
tion of change. One month later neurologic examination
revealed a mild degree of cognitive deficit, cerebellar signs
in the right upper extremity and apraxia. The patient
denied hospitalization for follow-up. Within ten days
insomnia, irritability and agitation emerged, and he expe-
rienced delusions of being killed by their relatives, his
speech became unintelligible and his gait instable. He was
admitted to the hospital after a generalized tonic-clonic
seizure. Neurological examination revealed drowsiness
and disorientation. Facial asymmetry was absent, and
extraocular movements were intact. Pupils were isochoric
and at the midline with normal direct and indirect light
reflexes. He was moving all his extremities in response to
painful stimuli. Postural and action tremors and diffuse
myoclonus emerging spontaneously and response to
auditory or tactile stimuli were observed. Deep tendon
reflexes were diminished, and planter reflexes were irrele-
vant bilaterally. Speech was extremely dysarthric and dif-
ficulty in swallowing was noted. Past medical history was
unremarkable. Any abnormality besides lower TSH levels
in laboratory tests could not be detected. From the 3rd day
of his hospitalization akinetic mutism developed. EEG
showed 4–5 cps teta waves in background activity and
also slow triphasic waves with higher amplitude on fron-
tal regions were detected. In differential diagnosis Hashi-
moto encephalitis was contemplated secondary to lower
levels of TSH. Laboratory findings of the patient were
interpreted as subclinical hyperthyrodism. Marked cere-
bral atrophy in frontoparietal regions and several
ischemic-gliotic foci were seen on cranial MRI, T2
weighted and FLAIR imaging, while hyperintense areas
(cortical ribboning) all over the cortex was noted in DW
MRI (Figure 1). Any increase in signal intensity was not
detected in putamen and caudate nucleus. In CSF exami-
nation protein, glucose and electrolyte levels were within
normal limits and no cell seen. However 14-3-3 protein
was positive. Patient diagnosed as sporadic CJD and died
within 4 months after the onset of his complaints.
Discussion
CJD is a fatally progressive prion disease characterized
with rapidly deteriorating dementia. Sporadic human
prion diseases are seen in 85–90% of the cases. Of the
remaining cases, 1–2% is the infectious form acquired
from an established source with the prion disease, 5–15%
is familial autosomal dominant type inherited secondary
to the mutation of prion protein gene localized on chro-
mosome 20 [1]. New variant CJD (nvCJD) has been
reported since middle of 90's. The mean age at the onset
of the disease is 29 years, and its mean survival is 16
months. Typical features of sporadic CJD could not be
observed. The protein 14-3-3 could not be detected in
CSF. This variant leads to cerebral prion plaques, contrary
to spongioform alterations in the brain tissue [3,4].
Familial CJD is associated with a relatively early onset
(40–50 years of age) and a prolonged course (22–24
months). Typical EEG findings are not seen, and genetic
studies revealed nearly 20 genes mutations. Iatrogenic
form can be occur secondary to duramater graft implanta-
tion, corneal transplantation, surgical operations per-
formed with contaminated instruments, and hormonal
therapies using hypophyseal growth hormones [1,5].
Symptoms of sporadic CJD can appear at 50–70 years of
age. It constitutes 90% of all cases with CJD and it is char-
The cortical ribboning sign on diffusion MRI of the patient Figure 1
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acterized with rapidly progressive dementia and myo-
clonus. Personality changes accompany cerebellar and
visual symptoms. Ataxia is more marked in advanced
cases and most patients have myoclonus manifesting as a
response to auditory and tactile stimuli. In late stages
patient develops akinetic mutism and myoclonus can dis-
appear. Eighty percent of the patients die from infection,
cardiac and respiratory failure within the first year [1]. CSF
protein levels rarely rise in CJD. Detection of a proteinase
inhibitor, 14-3-3 protein released from damaged neurons
into CSF fortifies the diagnosis [3,4]. Zerr et. al. found that
14-3-3 protein is 94% sensitive and 84% specific for the
disease [3]. This protein can be detected in viral encepha-
litis, Hashimoto encephalitis, amyotrophic lateral sclero-
sis, and other types of dementia. Besides 14-3-3 protein,
markers such as neuron specific enolase, amyloid beta,
tau protein, astrocytic protein S 100 and neopterin are
being investigated [4]. EEG does not reveal any patholog-
ical finding excluding nonspesific manifestations as nor-
mal or diffuse slowing, and frontal rhythmic delta activity.
Periodic biphasic or triphasic, synchronized sharp wave
complexes occuring during middle or late stages of disese
are typical and found 90% of the patients. Steinhoff in his
series of 150 cases reported 64% sensitivity and 91% spe-
cificity for EEG examinations. [5]. Zerr et al. found 66%
sensitivity and 74% specificity [3]. In terminal stages of
the disease where myoclonus are absent, typical EEG find-
ings can not be elicited [3,5].
In sporadic CJD cerebral atrophy, increase in signal inten-
sity in putamen, caudate nucleus and cerebral cortex can
be detected in imaging studies. Increased signal intensity
in the cortex is called ribboning. Shiga et al. revealed
92.3% sensitivity and 93% specificity for DW MRI in their
patients with definitive (n = 9) and probable (n = 36)
diagnoses of CJD [6]. Recent studies demonstrated that
even in very early stages of the disease pathological find-
ings can be detected with DW MR [6-9]. Definitive diag-
nosis of CJD requires neuropathological examinations.
Spongiofrom alterations, astroglyosis and neuronal losses
are detected in brain tissues obtained with biopsy or post-
mortem sampling. Detection of PrPSc reactivity with
immunohistochemical staining and demonstration of
protease resistant PrPSc have diagnostic value [2].
Conclusion
According to diagnostic criteria of World Health Organi-
zation (WHO) for the probable diagnosis of CDJ, the
presence of at least one criterion among typical EEG find-
ings and 14-3-3 positivity for CSF samples or at least 2 cri-
teria among myoclonus, visual disturbances, cerebellar,
pyramidal or extrapyramidal findings and akinetic mut-
ism together with progressive dementia are required. [10].
Among these criteria pathological EEG findings and the
presence of 14-3-3 protein in CSF samples were men-
tioned without considering MR findings. We though that
DW MRI should be appropriately considered among diag-
nostic armamentarium, because it is a non-invasive
screening tool with higher sensitivity and specificity than
biopsies.
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